Outset Medical Inc (OM) concluded trading on Wednesday at a closing price of $19.57, with 0.45 million shares of worth about $8.88 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.54% during that period and on June 18, 2025 the price saw a gain of about 3.33%. Currently the company’s common shares owned by public are about 17.72M shares, out of which, 16.94M shares are available for trading.
Stock saw a price change of -4.19% in past 5 days and over the past one month there was a price change of -0.05%. Year-to-date (YTD), OM shares are showing a performance of 17.54% which decreased to -66.11% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.85 but also hit the highest price of $72.60 during that period. The average intraday trading volume for Outset Medical Inc shares is 214.20K. The stock is currently trading 0.99% above its 20-day simple moving average (SMA20), while that difference is up 25.62% for SMA50 and it goes to 55.47% higher than SMA200.
Outset Medical Inc (NASDAQ: OM) currently have 17.72M outstanding shares and institutions hold larger chunk of about 83.07% of that.
The stock has a current market capitalization of $346.41M and its 3Y-monthly beta is at 2.14. It has posted earnings per share of -$29.22 in the same period. It has Quick Ratio of 6.74 while making debt-to-equity ratio of 0.58. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OM, volatility over the week remained 5.03% while standing at 4.41% over the month.
Stock’s fiscal year EPS is expected to rise by 80.74% while it is estimated to increase by 25.82% in next year. EPS is likely to grow at an annualized rate of 48.44% for next 5-years, compared to annual growth of -4.06% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on August 08, 2024 offering a Sector perform rating for the stock and assigned a target price range of between $6 and $3 to it. Coverage by RBC Capital Mkts stated Outset Medical Inc (OM) stock as an Outperform in their note to investors on June 21, 2024, suggesting a price target of $6 for the stock. On April 08, 2024, BTIG Research Initiated their recommendations, while on April 05, 2024, CL King Upgrade their ratings for the stock with a price target of $6. Stock get a Sector perform rating from RBC Capital Mkts on January 12, 2024.
